Sawai Pharmaceutical Co., Ltd. Share Price Japan Exchange
Equities
4555
JP3323050009
Pharmaceuticals
Sales 2024 | 177B 1.13B 94.38B | Sales 2025 * | 203B 1.3B 108B | Capitalization | 247B 1.58B 132B |
---|---|---|---|---|---|
Net income 2024 | 13.7B 87.52M 7.31B | Net income 2025 * | 19.69B 126M 10.51B | EV / Sales 2024 | 1.49 x |
Net Debt 2024 * | 34.69B 222M 18.51B | Net Debt 2025 * | 36.11B 231M 19.27B | EV / Sales 2025 * | 1.4 x |
P/E ratio 2024 |
19.3
x | P/E ratio 2025 * |
12.6
x | Employees | 3,393 |
Yield 2024 * |
2.3% | Yield 2025 * |
2.65% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/21/01 |
President | 66 | 01/21/01 | |
Toru Terashima
BRD | Director/Board Member | 64 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/21/01 |
Kenzo Sawai
BRD | Director/Board Member | 56 | 01/21/01 |
Masatoshi Ohara
BRD | Director/Board Member | 73 | 01/21/01 |
1st Jan change | Capi. | |
---|---|---|
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |